Jun 2026 (Q2 FY26) — Aug 6, 2026
Genworth Q2 FY26 — Strong Enact Performance and CareScout Expansion Offset Closed Block A/E Losses
Read the full callGenworth (GNW) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Genworth earnings: last reported Thu, 6 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 1,901 | +5.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | Operating profit / revenue | Quarter to Jun 2026 | Not in the filed figures for the quarter to jun 2026. No older figure is substituted. | ||
| Net profit | 47.0 | −7.8% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
Price
$8.94 −1.43% · −$0.13
Performance +4.6% 1Y
1Y: $8.55 on 17 Oct 2025 → $8.94. High $10.6 (14 Sept 2026), low $7.94 (13 Mar 2026).
- Previous close
- $9.07
- 52-week range
- $7.94 – $10.6
- One year
- +3.11%
Overview
- Symbol
- GNW
- Sector
- Financials
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q1 FY26) — May 6, 2026
Genworth Financial Q1 FY26 — Strong ANAC Performance Fuels Capital Returns and CareScout Growth
Read the full callDec 2025 (Q4 FY25) — Feb 24, 2026
Genworth Financial Q4 FY25 — Strong Enact Performance Fuels Share Repurchases and CareScout Growth
Read the full callEvery analysed call
Genworth earnings calls (GNW)
Financials
What the filings say
Net profit, year on year: −8% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1,880 | 1,782 | 1,786 | 1,796 | 1,935 | 1,784 | 1,777 | 1,901 |
| Operating profit | 48 | — | 51 | 68 | — | — | — | — |
| Operating margin | 2.5% | — | 2.9% | 3.8% | — | — | — | — |
| Interest | 28 | 27 | 26 | 26 | 27 | 26 | 25 | 26 |
| Profit before tax | 161 | 55 | 126 | 125 | 164 | 18 | 111 | 109 |
| Tax rate | 24.8% | 36.4% | 28.6% | 28.0% | 5.5% | 22.2% | 27.9% | 23.9% |
| Net profit | 85 | -1 | 54 | 51 | 116 | 2 | 47 | 47 |
| EPS ($ per share) | 0.20 | — | 0.13 | 0.12 | 0.29 | — | 0.12 | 0.12 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reserves | 1,118 | 1,461 | 1,584 | 2,490 | 1,139 | 1,213 | 1,462 | 1,684 |
| Total liabilities | 86,734 | 86,710 | 89,927 | 82,905 | 81,328 | 82,482 | 77,440 | 78,316 |
| Total assets | 100,923 | 101,342 | 105,747 | 99,171 | 89,714 | 90,817 | 86,821 | 88,083 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1,633 | 2,079 | 1,960 | 437 | 1,049 | 597 | 88 | 327 |
| Cash from investing | -622 | 1,301 | -1,153 | 896 | 733 | 1,261 | 861 | 518 |
| Cash from financing | -1,621 | -2,217 | -1,507 | -2,419 | -1,554 | -1,443 | -1,115 | -857 |
| Net cash flow | -698 | 1,164 | -685 | -1,085 | 228 | 416 | -167 | -12 |
GNW operating KPIs by quarter
| KPI | Dec 2025 Q4 FY25 | Mar 2026 Q1 FY26 | Jun 2026 Q2 FY26 | Change vs prior quarter |
|---|---|---|---|---|
| CareScout matches CareScout Services | 925The team executed well in the fourth quarter, facilitating 925 matches between LTC policyholders and home care providers in our network.Source: earnings call transcript | ~1,500We facilitated approximately 1,500 matches between care seekers and providers in the first quarter reflecting strong sequential and year-over-year growth.Source: earnings call transcript | ~1,450We facilitated approximately 1,450 matches between care seekers and providers in the second quarter, bringing total matches for the first half of the year to approximately 2,950, over double the number of matches achieved in the first half of 2025.Source: earnings call transcript | — |
| New insurance written Enact | $14BNew insurance written of $14 billion in the quarter increased versus the prior quarter and prior year.Source: earnings call transcript | $13BNew insurance written of $13 billion in the quarter decreased versus the prior quarter, primarily based on seasonal trends but increased versus the prior year as a result of lower interest rates early in the quarter.Source: earnings call transcript | $15BNew insurance written of $15 billion in the quarter was seasonally higher than the prior quarter, an increase versus the prior year as a result of a larger estimated market size.Source: earnings call transcript | +15.4% |
| Primary insurance in-force Enact | $273BPrimary insurance in-force grew slightly year-over-year to $273 billion, supported by both the growth in new insurance written and continued elevated persistency.Source: earnings call transcript | $272BPrimary insurance in force increased year-over-year to $272 billion supported by the growth in new insurance written and continued elevated persistency.Source: earnings call transcript | $274BPrimary insurance in force increased 2% year-over-year to $274 billion, supported by new insurance written and continued elevated persistency.Source: earnings call transcript | +0.7% |
| PMIERs sufficiency ratio Enact | 162%Enact's estimated PMIERs sufficiency ratio remained strong at 162% or approximately $1.9 billion above requirements.Source: earnings call transcript | 162%In Act estimated PMIERs sufficiency ratio remained strong at 162% or approximately $1.9 billion above requirements.Source: earnings call transcript | 161%Enact's estimated PMIERs sufficiency ratio remained strong at 161% or approximately $1.9 billion above requirements.Source: earnings call transcript | -1 pt |
Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.
Insider filings
81 filings between Nov 10, 2025 and Sep 3, 2026.
Open market
decisions to buy or sellPurchases
None
No insider bought shares.
Sales
$3.66M
7 sales by 4 insiders
Compensation
not trading decisions- 9
- Award — granted as compensation
- 31
- Option exercise — converted options into shares
- 31
- Tax withheld — shares kept back by the company to cover tax
Also filed: 3 gifts.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| McInerney Thomas J | — | $2.33M | Sep 3, 2026 |
| Karawan Gregory S. | — | $736.9K | Aug 21, 2026 |
| RESTREPO ROBERT P JR | — | $456.1K | May 22, 2026 |
| Hagerman Melissa | — | $145.8K | Aug 24, 2026 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | McInerney Thomas J President and CEO; Director | Sale | 100,000 | $1.05M |
| Aug 24, 2026 | Hagerman Melissa EVP and Chief HR Officer | Sale | 14,708 | $145.8K |
| Aug 24, 2026 | Hagerman Melissa EVP and Chief HR Officer | Gift | 11,000 | $0 |
| Aug 21, 2026 | Karawan Gregory S. EVP and General Counsel | Sale | 40,000 | $396.5K |
| Jul 13, 2026 | Shah Samir B. Pres. & CEO, CareScout | Option exercise | 15,965 | — |
| Jul 13, 2026 | Shah Samir B. Pres. & CEO, CareScout | Tax withheld | 8,160 | $77.3K |
| May 27, 2026 | McInerney Thomas J President and CEO; Director | Gift | 200,000 | $0 |
| May 22, 2026 | McInerney Thomas J President and CEO; Director | Sale | 100,000 | $927.0K |
| May 22, 2026 | RESTREPO ROBERT P JR Director | Sale | 50,000 | $456.1K |
| May 21, 2026 | Taylor Morris C. EVP & CIO | Tax withheld | 6,478 | $59.5K |
| May 21, 2026 | Taylor Morris C. EVP & CIO | Option exercise | 21,521 | — |
| May 20, 2026 | Smith Ramsey D. Director | Award | 18,264 | $165.0K |
| May 20, 2026 | Sarsynski Elaine A Director | Award | 32,100 | $290.0K |
| May 20, 2026 | Conrad G Kent Director | Award | 18,264 | $165.0K |
| May 20, 2026 | HIGGINS MELINA E Director | Award | 31,547 | $285.0K |
| May 20, 2026 | Mills Howard D. III Director | Award | 18,264 | $165.0K |
| May 20, 2026 | Goodman Jill R Director | Award | 18,264 | $165.0K |
| May 20, 2026 | Dyson Karen Elizabeth Director | Award | 18,264 | $165.0K |
| May 20, 2026 | Van Wyk Steven C. Director | Award | 32,100 | $290.0K |
| May 20, 2026 | RESTREPO ROBERT P JR Director | Award | 18,264 | $165.0K |
| Mar 2, 2026 | Saltzgaber Kelly A EVP & Chief Investment Officer | Option exercise | 49,918 | $0 |
| Mar 2, 2026 | Hodges Mark Blakeley EVP and Chief Risk Officer | Tax withheld | 22,514 | $190.5K |
| Mar 2, 2026 | Hodges Mark Blakeley EVP and Chief Risk Officer | Option exercise | 49,918 | $0 |
| Mar 2, 2026 | Hagerman Melissa EVP and Chief HR Officer | Tax withheld | 22,514 | $190.5K |
| Mar 2, 2026 | Hagerman Melissa EVP and Chief HR Officer | Option exercise | 49,918 | $0 |
| Mar 2, 2026 | Karawan Gregory S. EVP and General Counsel | Option exercise | 49,918 | $0 |
| Mar 2, 2026 | Karawan Gregory S. EVP and General Counsel | Tax withheld | 22,514 | $190.5K |
| Mar 2, 2026 | McInerney Thomas J President and CEO; Director | Tax withheld | 304,135 | $2.57M |
| Mar 2, 2026 | Upton Jerome T EVP & Chief Financial Officer | Tax withheld | 36,555 | $309.3K |
| Mar 2, 2026 | Saltzgaber Kelly A EVP & Chief Investment Officer | Tax withheld | 23,133 | $195.7K |
| Mar 2, 2026 | Upton Jerome T EVP & Chief Financial Officer | Option exercise | 83,196 | $0 |
| Mar 2, 2026 | McInerney Thomas J President and CEO; Director | Option exercise | 665,574 | $0 |
| Mar 2, 2026 | Arland Jamala M. Pres. & CEO, U.S. Life Ins. | Option exercise | 24,959 | $0 |
| Mar 2, 2026 | Shah Samir B. Pres. & CEO, CareScout Svcs. | Tax withheld | 18,595 | $157.3K |
| Mar 2, 2026 | Shah Samir B. Pres. & CEO, CareScout Svcs. | Option exercise | 36,381 | $0 |
| Mar 2, 2026 | Arland Jamala M. Pres. & CEO, U.S. Life Ins. | Tax withheld | 11,257 | $95.2K |
| Feb 26, 2026 | Hodges Mark Blakeley EVP and Chief Risk Officer | Option exercise | 18,753 | — |
| Feb 26, 2026 | Hodges Mark Blakeley EVP and Chief Risk Officer | Tax withheld | 6,537 | $56.3K |
| Feb 26, 2026 | Hodges Mark Blakeley EVP and Chief Risk Officer | Option exercise | 21,716 | — |
| Feb 26, 2026 | Hagerman Melissa EVP and Chief HR Officer | Option exercise | 23,441 | — |
| Feb 26, 2026 | Hagerman Melissa EVP and Chief HR Officer | Tax withheld | 6,537 | $56.3K |
| Feb 26, 2026 | Hagerman Melissa EVP and Chief HR Officer | Option exercise | 21,716 | — |
| Feb 26, 2026 | Karawan Gregory S. EVP and General Counsel | Tax withheld | 7,026 | $60.6K |
| Feb 26, 2026 | Karawan Gregory S. EVP and General Counsel | Option exercise | 25,316 | — |
| Feb 26, 2026 | Karawan Gregory S. EVP and General Counsel | Tax withheld | 7,533 | $64.9K |
| Feb 26, 2026 | Hagerman Melissa EVP and Chief HR Officer | Tax withheld | 7,056 | $60.8K |
| Feb 26, 2026 | Karawan Gregory S. EVP and General Counsel | Option exercise | 27,144 | — |
| Feb 26, 2026 | Upton Jerome T EVP & Chief Financial Officer | Tax withheld | 10,415 | $89.8K |
| Feb 26, 2026 | Upton Jerome T EVP & Chief Financial Officer | Option exercise | 37,506 | — |
| Feb 26, 2026 | Upton Jerome T EVP & Chief Financial Officer | Tax withheld | 11,548 | $99.5K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for GENWORTH FINANCIAL INC
Free account. Everything above stays public.
Write why you follow GENWORTH FINANCIAL INC and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading